Dengue fever dataset

This dataset is hosted by another domain.

Monster hunter_ world pc audio desync

Skip to main content Skip to footer links. Clear All. Tags nedss netss nndss wonder osh tobacco cdc centers for disease control and prevention state system survey office on smoking and health prevalence brfss mmwr policy behavioral risk legislation tobacco use census cardiovascular disease mental health reproductive health factor nchs oral health smoking united states Federated Domains This site only chronicdata. Cryptosporidiosis to Dengue Hemorrhagic Fever - The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.

Data on United States exclude counts from US territories. Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. U: Unavailable. N: Not reportable. Med: Median. Max: Maximum.

Tags dengue hemorrhagic fever dengue fever cryptosporidiosis netss nedss and 4 more.

Dengue fever

API Docs. August 27 Showing 1 result. Close You are leaving data.This page lists all the epidemiological data sets currently available througth VBRC.

Estimates were made for BCG, the third dose of diphtheria and tetanus toxoid and pertussis vaccine DTP3the third dose of polio vaccine - either oral polio vaccine or inactivated polio vaccine Pol3 - the first dose of measles vaccine MCV and the third dose of hepatitis B vaccine HepB3. We have also made estimates of the proportion of live births protected PAB through maternal immunization with at least two doses of tetanus toxoid for country where the risk of neonatal tetanus is a significant public health problem for the year onward.

In we added estimates of the first dose. This system is provided for authorized users only. Anyone using this system expressly consents to monitoring while using the system.

Improper use of this system may be referred to law enforcement officials. This project is funded by the U. This is a collaboration between the University of Chicago and J. Craig Venter Institute. More columns were returned than can be displayed without scrolling.

Use scroll bars at top and bottom of display to move right and left or reduce the number of columns displayed by using the Display Settings link above. Can include optional percentages in parentheses after each type. Cases DF.

dengue fever dataset

IR DF. Comma separated list of circulating serotypes. Antigen coverage BCG. Antigen coverage DTP1.

Novas musica tima mp4

Incidence of first dose of diphtheria toxoid, tetanus toxoid and pertussis DTP1 vaccine coverage. Antigen coverage DTP3. Incidence of third dose of diphtheria toxoid, tetanus toxoid and pertussis DTP3 vaccine coverage.

Circular array c

Antigen coverage HepB3. Incidence of third dose of Haemophilus influenzae type B vaccine coverage. Antigen coverage Hib3. Antigen coverage MCV. Antigen coverage PAB. Antigen coverage Pol3. Antigen coverage CRS.

Exploring infections through data: Dengue fever

Antigen coverage Mumps. Antigen coverage Rubella. Antigen coverage MCV2. Antigen coverage VAD1. Antigen coverage YFV.

dengue fever dataset

Antigen coverage yfever.Dengue DENG-gey fever is a mosquito-borne disease that occurs in tropical and subtropical areas of the world. Mild dengue fever causes a high fever, rash, and muscle and joint pain.

Epidemiological Datasets

A severe form of dengue fever, also called dengue hemorrhagic fever, can cause severe bleeding, a sudden drop in blood pressure shock and death. Millions of cases of dengue infection occur worldwide each year. Dengue fever is most common in Southeast Asia and the western Pacific islands, but the disease has been increasing rapidly in Latin America and the Caribbean. Researchers are working on dengue fever vaccines. For now the best prevention is to reduce mosquito habitat in areas where dengue fever is common.

Many people, especially children and teens, may experience no signs or symptoms during a mild case of dengue fever. When symptoms do occur, they usually begin four to seven days after you are bitten by an infected mosquito. Dengue fever causes a high fever — F degrees — and at least two of the following symptoms:. Most people recover within a week or so. In some cases, symptoms worsen and can become life-threatening.

Blood vessels often become damaged and leaky. And the number of clot-forming cells platelets in your bloodstream drops. This can cause a severe form of dengue fever, called dengue hemorrhagic fever, severe dengue or dengue shock syndrome. Signs and symptoms of dengue hemorrhagic fever or severe dengue — a life-threatening emergency — include:.

Call or go to the nearest emergency room if you've recently visited a region in which dengue fever is known to occur and you develop emergency symptoms, such as severe abdominal pain, vomiting, difficulty breathing, or blood in your nose, gums, vomit or stools. Dengue fever is caused by any one of four types of dengue viruses spread by mosquitoes that thrive in and near human lodgings.

When a mosquito bites a person infected with a dengue virus, the virus enters the mosquito. When the infected mosquito then bites another person, the virus enters that person's bloodstream. After you've recovered from dengue fever, you have immunity to the type of virus that infected you — but not to the other three dengue fever virus types.

The risk of developing severe dengue fever, also known as dengue hemorrhagic fever, actually increases if you're infected a second, third or fourth time. Factors that put you at greater risk of developing dengue fever or a more severe form of the disease include:. If severe, dengue fever can damage the lungs, liver or heart.

Blood pressure can drop to dangerous levels, causing shock and, in some cases, death. One dengue fever vaccine, Dengvaxia, is currently approved for use in those ages 9 to 45 who live in areas with a high incidence of dengue fever.

The vaccine is given in three doses over the course of 12 months.Skip directly to site content Skip directly to page options Skip directly to A-Z link. Section Navigation. Dengue in the US States and Territories.

Challenge Summary

Minus Related Pages. Dengue outbreaks occasionally occur in the continental United States. Nearly all dengue cases reported in the 48 contiguous US states were in travelers infected elsewhere. Most outbreaks in the United States have been relatively small and limited to small areas. Because the types of mosquitoes that spread dengue are common throughout many areas of the United Stateslocal spread of dengue is possible.

Get Email Updates.

Emmc bga 162

To receive email updates about this page, enter your email address: Email Address. Links with this icon indicate that you are leaving the CDC website. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.

You will be subject to the destination website's privacy policy when you follow the link. CDC is not responsible for Section compliance accessibility on other federal or private website. Cancel Continue.Dengue fever is a mosquito-borne disease that occurs in tropical and sub-tropical parts of the world.

In mild cases, symptoms are similar to the flu: fever, rash, and muscle and joint pain. In severe cases, dengue fever can cause severe bleeding, low blood pressure, and even death. Because it is carried by mosquitoes, the transmission dynamics of dengue are related to climate variables such as temperature and precipitation.

Although the relationship to climate is complex, a growing number of scientists argue that climate change is likely to produce distributional shifts that will have significant public health implications worldwide. In recent years dengue fever has been spreading. Historically, the disease has been most prevalent in Southeast Asia and the Pacific islands. These days many of the nearly half billion cases per year are occurring in Latin America:. Using environmental data collected by various U.

Department of Commerce —can you predict the number of dengue fever cases reported each week in San Juan, Puerto Rico and Iquitos, Peru?

This is an intermediate-level practice competition. Your task is to predict the number of dengue cases each week in each location based on environmental variables describing changes in temperature, precipitation, vegetation, and more.

An understanding of the relationship between climate and dengue dynamics can improve research initiatives and resource allocation to help fight life-threatening pandemics. Mosquito image courtesy of flickr user sanofi-pasteur. You cannot sign up to DrivenData from multiple accounts and therefore you cannot submit from multiple accounts. DrivenData and the competition host have the right to publicly disseminate any entries or models.

Winning solutions must be documented using the provided Winning Model Documentation Template in order to be eligible for recognition and prize money if offered. The number of submissions per day is restricted to a fixed value on a per-competition basis.

Any attempt to circumvent this limit will result in disqualification. External data is not allowed unless otherwise noted explicitly on these competition pages. Participants agree to make no attempt to use additional data or data sources not provided on these competition pages. These are the complete, official rules for the Competition the 'Competition Rules' and incorporate by reference the contents of the Competition Website listed above.

By downloading a dataset linked from the Competition Website, submitting an entry to this Competition, or joining a Team in this Competition, you are agreeing to be bound by these Competition Rules which constitute a binding agreement between you and DrivenData and, if applicable, any rules and restrictions that may be imposed by the Competition Sponsor.

The Competition will run according to the dates listed on the Competition Website. Each registered individual or Team is referred to as a Participant. Competing using more than one DrivenData account per individual is a breach of these Competition Rules and Competition Sponsor reserves the right to disqualify any individual or Team including an individual who is found to breach these Competition Rules.Models describing dengue epidemics are parametrized on disease incidence data and therefore high-quality data are essential.

For Thailand, two different sources of long-term dengue data are available, the hard copy data from towhere hospital admission cases were notified, and the electronic files, from to the present, where clinically classified forms of disease, i. The official dengue notification data, provided by the Bureau of Epidemiology, Ministry of Public Health in Thailand, were cross-checked with dengue data used in recent publications, where an inexact continuous time-series was observed to be consistently used sinceaffecting considerably the model dynamics and its correct application.

In this paper, numerical analysis and simulation techniques giving insights on predictability are performed to show the effects of model parametrization by using different datasets.

Epidemic models have been important in understanding the spread of infectious diseases and evaluating the introduction of intervention strategies like vector control and vaccination.

Infectious disease dynamics are by nature nonlinear and the understanding of such nonlinear epidemiological processes is vital for any modern society, from the medical as well as the economic perspective. However, it is intrinsically mathematically difficult, and to make the urgently needed progress in improving our understanding of the dynamics of infectious diseases, concepts from various fields of mathematics as well the availability of good-quality datasets for model evaluation are needed.

Dengue fever DFa viral mosquito-borne infection is a major international public health concern with about 3 billion people at risk of acquiring the infection [ 1 ].

Multiplying polynomials activity

DF is an acute febrile viral disease frequently presenting with headaches, bone or joint and muscular pains, rash and leukopenia as symptoms. DHF is characterized by four major clinical manifestations: high fever, haemorrhagic phenomena, often with hepatomegaly and, in severe cases, signs of circulatory failure.

Infected patients may develop hypovolaemic shock resulting from plasma leakage. This is designated DSS and can be fatal [ 3 ]. Inthe revised WHO case definition was proposed, classifying the illness into dengue with and without warning signs, and severe dengue [ 4 ]. The revised scheme is claimed to be more sensitive to the diagnosis of severe dengue; however, it is considered by many to be too broad, requiring more specific definition of warning signs [ 5 ].

Dengue fever epidemiology dynamics show large fluctuations of disease incidence and mathematical models describing transmission of disease ultimately aim to be used as predictive tools to evaluate the introduction of intervention strategies. Both DF and DHF without shock can be written in the Thai language using the same combination of letters as depicted in Figure 1 [items 1 and 2 ]. If DF cases are often benign or asymptomatic, DHF cases may evolve towards a group of symptoms with haemorrhagic fever leading to shock or DSS, that when written in the Thai language, uses a different combination of letters [see Fig.

Up to now, 33 years of dengue illness incidence data in Thailand are available and have been continually used by modellers to parametrize mathematical models see e. Dengue illness notification diagram and etymology. Items 12 and 3 give disease classification according to the WHO [ 3 ]. We present the Thai written form followed by the English pronunciation in parentheses and the Thai internal classification code for disease notification for more information, see Appendix A.

In this paper, a systematic data collection and its analysis were performed.

Are you safe from Latin America's Dengue fever epidemic?

The official data was cross-checked with the data used in recent publications and an inexact continuous time-series appeared to have been consistently used sinceaffecting considerably the model dynamics and its correct application.

Here, the inexact continuous time-series reflects a time-series on the incidence of the disease where only part of the official data from onwards has been used to continue the previous available data from to Two different datasets, based on the interpretation of the Thai official documents, generated different model dynamics that could be used as a public health intervention tool.

Numerical analysis and simulation techniques giving insights on predictability were performed and the modelling parametrization effects discussed.

dengue fever dataset

Reasonable data from all provinces exist from the beginning of the s [ 21213 ]. From to the aggregated monthly incidence data have been publicly distributed through BoE annual epidemiological surveillance reports [ 12 ]. These data are available as a hard copy HC book format and the incidence of all hospital admissions for dengue cases DF, DHF, DSSreported to the national surveillance system, are presented as the dengue haemorrhagic fever total DHF-total.

The aggregation of all hospital admission cases, gives rise to the HC-DHF-total incidence data and this has been available, sinceas BOE weekly epidemiological surveillance reports. The official monthly incidence of dengue illness is presented for Chiang Mai Fig.

For the epidemiological yearsand both sources of data are available, i. Data comparison between hard copy dengue haemorrhagic fever DHF -total and electronic files for dengue fever DFDHF and dengue shock syndrome DSSrespectively, for Chiang Mai province, in abc ; d is a histogram for the underestimation of dengue cases, from to the present.Dengue fever is a mosquito-borne tropical disease caused by the dengue virus.

Dengue is spread by several species of female mosquitoes of the Aedes typeprincipally A. A vaccine for dengue fever has been approved and is commercially available in a number of countries.

Dengue has become a global problem since the Second World War and is common in more than countries, mainly in Asia and South America. The characteristic symptoms of dengue are sudden-onset fever, headache typically located behind the eyesmuscle and joint pains, and a rash.

An alternative name for dengue, "breakbone fever", comes from the associated muscle and joint pains. In some people, the disease proceeds to a critical phase as fever resolves. The recovery phase occurs next, with resorption of the leaked fluid into the bloodstream.

Dengue can occasionally affect several other body systems[19] either in isolation or along with the classic dengue symptoms. A pregnant woman who develops dengue is at higher risk of miscarriagelow birth weight birth, and premature birth. Other members of the same genus include yellow fever virusWest Nile virusZika virusSt. Louis encephalitis virusJapanese encephalitis virustick-borne encephalitis virusKyasanur forest disease virusand Omsk hemorrhagic fever virus.

The dengue virus genome genetic material contains about 11, nucleotide baseswhich code for the three different types of protein molecules C, prM and E that form the virus particle and seven other non-structural protein molecules NS1, NS2a, NS2b, NS3, NS4a, NS4b, NS5 that are found in infected host cells only and are required for replication of the virus.

Dengue virus is primarily transmitted by Aedes mosquitos, particularly A. The virus seems to have no detrimental effect on the mosquito, which remains infected for life. Dengue can also be transmitted via infected blood products and through organ donation.

dengue fever dataset

Severe disease is more common in babies and young children, and in contrast to many other infections, it is more common in children who are relatively well nourished. Polymorphisms normal variations in particular genes have been linked with an increased risk of severe dengue complications. When a mosquito carrying dengue virus bites a person, the virus enters the skin together with the mosquito's saliva.

It binds to and enters white blood cellsand reproduces inside the cells while they move throughout the body. The white blood cells respond by producing several signaling proteins, such as cytokines and interferonswhich are responsible for many of the symptoms, such as the fever, the flu-like symptoms, and the severe pains.

In severe infection, the virus production inside the body is greatly increased, and many more organs such as the liver and the bone marrow can be affected. Fluid from the bloodstream leaks through the wall of small blood vessels into body cavities due to capillary permeability. As a result, less blood circulates in the blood vessels, and the blood pressure becomes so low that it cannot supply sufficient blood to vital organs.

Furthermore, dysfunction of the bone marrow due to infection of the stromal cells leads to reduced numbers of platelets, which are necessary for effective blood clotting; this increases the risk of bleeding, the other major complication of dengue fever. Once inside the skin, dengue virus binds to Langerhans cells a population of dendritic cells in the skin that identifies pathogens.

Meanwhile, the virus genome is translated in membrane-bound vesicles on the cell's endoplasmic reticulumwhere the cell's protein synthesis apparatus produces new viral proteins that replicate the viral RNA and begin to form viral particles.

Immature virus particles are transported to the Golgi apparatusthe part of the cell where some of the proteins receive necessary sugar chains glycoproteins. The now mature new viruses are released by exocytosis. They are then able to enter other white blood cells, such as monocytes and macrophages.

The initial reaction of infected cells is to produce interferona cytokine that raises many defenses against viral infection through the innate immune system by augmenting the production of a large group of proteins mediated by the JAK-STAT pathway.

Some serotypes of the dengue virus appear to have mechanisms to slow down this process. Interferon also activates the adaptive immune systemwhich leads to the generation of antibodies against the virus as well as T cells that directly attack any cell infected with the virus.


thoughts on “Dengue fever dataset

Leave a Reply

Your email address will not be published. Required fields are marked *